Skip to main content

NHG-Standaard Amenorroe

Eerste herziening

  • Chapter
NHG-Standaarden 2009

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatuur

  • Bij verwijzingen naar NHG-producten: zie http://www.nhg.org.

  • Aronson JK. Meyler’s side effects of drugs: the international encyclopedia of adverse drug reactions and interactions. 15th ed. Amsterdam: Elsevier, 2006.

    Google Scholar 

  • Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9: 505–514.

    Article  PubMed  Google Scholar 

  • Beals KA. Eating behaviors, nutritional status, and menstrual function in elite female adolescent volleyball players. J Am Diet Assoc 2002;102: 1293–1296.

    Article  PubMed  Google Scholar 

  • Broekmans FJ, Scheffer GJ, Bancsi LF, Dorland M, Blankenstein MA, Te Velde ER. Ovarian reserve tests in infertility practice and normal fertile women. Maturitas 1998;30: 205–214.

    Article  PubMed  CAS  Google Scholar 

  • Commissie Aanvullende Diagnostiek van het College voor zorgverzekeringen. Diagnostisch Kompas. Amstelveen: College voor zorgverzekeringen, 2003.

    Google Scholar 

  • Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61: 403–407.

    PubMed  CAS  Google Scholar 

  • Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91: 492–487.

    Article  PubMed  CAS  Google Scholar 

  • Davajan V, Kletzky O, March CM, Roy S, Mishell DR, Jr. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea. Am J Obstet Gynecol 1978;130: 894–904.

    PubMed  CAS  Google Scholar 

  • Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106: 131–137.

    PubMed  Google Scholar 

  • Dueck CA, Matt KS, Manore MM, Skinner JS. Treatment of athletic amenorrhea with a diet and training intervention program. Int J Sport Nutr 1996;6: 24–40.

    PubMed  CAS  Google Scholar 

  • Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28: 341–359.

    Article  PubMed  CAS  Google Scholar 

  • Duijkers I, Engels L, Klipping C. Length of the menstrual cycle after discontinuation of oral contraceptives. Gynecol Endocrinol 2005;20: 74–79.

    Article  PubMed  CAS  Google Scholar 

  • Elders PJM, Leusink GL, Graafmans WC, Bolhuis AP, Van der Spoel OP, Van Keimpema JC, et al. NHG-Standaard Osteoporose. Huisarts Wet 2005;48: 559–570.

    Google Scholar 

  • Falkenberry SS. Nipple discharge. Obstet Gynecol Clin North Am 2002;29: 21–29.

    Article  PubMed  Google Scholar 

  • Falsetti L, Gambera A, Barbetti L, Specchia C. Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors. J Clin Endocrinol Metab 2002;87: 500–505.

    Article  PubMed  CAS  Google Scholar 

  • Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae K. Oral contraceptives and venous thromboembolic disease: Analyses of the UK General Practice Research Database and the UK Mediplus database. Hum Reprod Update 1999;5: 688–706.

    Article  PubMed  CAS  Google Scholar 

  • French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004;CD001776.

    Google Scholar 

  • Glueck CJ, Dharashivkar S, Wang P, Zhu B, Gartside PS, Tracy T, et al. Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. Eur J Obstet Gynecol Reprod Biol 2005;122: 206–212.

    Article  PubMed  Google Scholar 

  • Gnoth C, Frank-Herrmann P, Schmoll A, Godehardt E, Freundl G. Cycle characteristics after discontinuation of oral contraceptives. Gynecol Endocrinol 2002;16: 307–317.

    Article  PubMed  CAS  Google Scholar 

  • Goodman LR, Warren MP. The female athlete and menstrual function. Curr Opin Obstet Gynecol 2005;17: 466–470.

    Article  PubMed  Google Scholar 

  • Guzick DS. Polycystic ovary syndrome. Obstet Gynecol 2004;103: 181–193.

    PubMed  CAS  Google Scholar 

  • Heineman MJ, Bleker OP, Evers JLH, Heints APM, redactie. Obstetrie en gynaecologie: devoortplanting van de mens. 2e druk. Maarssen: Elsevier gezondheidszorg, 2004.

    Google Scholar 

  • Heinemann LA, Will-Shahab L, Van Kesteren P, Gooren LJ. Safety of cyproterone acetate: report of active surveillance. Pharmacoepidemiol Drug Saf 1997;6: 169–178.

    Article  PubMed  CAS  Google Scholar 

  • Heuser P, Tonga K, Hopkins R, Henderson M, Weatherall M, Metcalfe S, et al. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission. NZ Med J 2004;117: U1176.

    Google Scholar 

  • Hoyt KL, Schmidt MC. Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment. Clin Lab Sci 2004;17: 155–163.

    PubMed  Google Scholar 

  • Jensen JT. Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview. Obstet Gynecol Surv 2005;60: 604–612.

    Article  PubMed  Google Scholar 

  • KaunitzAM. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Int J Fertil Womens Med 1998;43: 73–83.

    PubMed  CAS  Google Scholar 

  • Koebnick C, Strassner C, Hoffmann I, Leitzmann C. Consequences of along-term raw food diet on body weight and menstruation: Results of a questionnaire survey. Ann Nutr Metab 1999;43: 69–79.

    Article  PubMed  CAS  Google Scholar 

  • Kopp-Woodroffe SA, Manore MM, Dueck CA, Skinner JS, Matt KS. Energy and nutrient status of amenorrheic athletes participating in a diet and exercise training intervention program. Int J Sport Nutr 1999;9: 70–88.

    PubMed  CAS  Google Scholar 

  • Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie. Informatorium Medicamentorum. Den Haag: KNMP, 2006.

    Google Scholar 

  • Kuchenbecker WK, RuifrokAE, BolsterJH, Heineman MJ, Hoek A. Subfertiliteit bij vrouwen met overgewicht. Ned Tijdschr Geneeskd 2006;150: 2479–2483.

    PubMed  CAS  Google Scholar 

  • Legro RS. Polycystic ovary syndrome: Current and future treatment paradigms. Am J Obstet Gynecol 1998;179: S101–S108.

    Article  PubMed  CAS  Google Scholar 

  • Leung AK, Pacaud D. Diagnosis and management of galactorrhea. Am Fam Physician 2004;70: 543–550.

    PubMed  Google Scholar 

  • Lidegaard O. Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol. J Obstet Gynaecol Can 2003;25: 575–577.

    PubMed  Google Scholar 

  • Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med 1999;44: 1085–1090.

    Google Scholar 

  • Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 2002;77: 919–927.

    Article  PubMed  Google Scholar 

  • Nederlandse Vereniging voor Obstetrie en Gynaecologie. Richtlijn Diagnostiek en behandeling van prematuur en ovarieel falen. Utrecht: NVOG, 2001. http://www.nvog.nl, geraadpleegdjanuari 2007.

  • Okkes IM, Oskam SK, Lamberts H. Van klacht naar diagnose: episodegegevens uit de huisartspraktijk. Bussum: Coutinho, 1998.

    Google Scholar 

  • Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab 1999;84: 1905–1911.

    Article  PubMed  CAS  Google Scholar 

  • Perkins RB, Hall JE, Martin KA. Aetiology, previous menstrual function and patterns of neuro-endocrine disturbance as prognostic indicators in hypothalamic amenorrhoea. Hum Reprod 2001;16: 2198–2205.

    Article  PubMed  CAS  Google Scholar 

  • Phillips OP. New aspects of injectable contraception. Int J Fertil Womens Med 2001;46: 31–36.

    PubMed  CAS  Google Scholar 

  • PorcileA, Gallardo E. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives. Fertil Steril 1991;55: 877–881.

    PubMed  CAS  Google Scholar 

  • Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: A study of 252 patients. Am J Obstet Gynecol 1981;140: 371–380.

    PubMed  CAS  Google Scholar 

  • Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 1986;155: 531–543.

    PubMed  CAS  Google Scholar 

  • Rencken ML, Chesnut CH, III, Drinkwater BL. Bone density at multiple skeletal sites in amenorrheic athletes. JAMA 1996;276: 238–240.

    Article  PubMed  CAS  Google Scholar 

  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288: 321–333.

    Article  PubMed  CAS  Google Scholar 

  • Saleh AM, Khalil HS. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2004;83: 614–621.

    Article  PubMed  Google Scholar 

  • Schlechte J, Sherman B, Halmi N, Van GilderJ, Chapler F, Dolan K, et al. Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study. Endocr Rev 1980;1: 295–308.

    Article  PubMed  CAS  Google Scholar 

  • Schlechte JA. Clinical practice: Prolactinoma. N Engl J Med 2003;349: 2035–2041.

    Article  PubMed  CAS  Google Scholar 

  • Seaman HE, DeVries CS, Farmer RD. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD. Pharmacoepidemiol Drug Saf 2003;12: 541–550.

    Article  PubMed  CAS  Google Scholar 

  • Seaman HE, DeVries CS, Farmer RD. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): Observational studies using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2004;13: 427–436.

    Article  PubMed  CAS  Google Scholar 

  • Shangold MM, Tomai TP, Cook JD, Jacobs SL, Zinaman MJ, Chin SY, et al. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea. Fertil Steril 1991;56: 1040–1047.

    PubMed  CAS  Google Scholar 

  • St-Jean E, Blain F, Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 1996;44: 305–309.

    Article  CAS  Google Scholar 

  • Tang T, GlanvilleJ, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome: A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 2006;21: 80–89.

    Article  PubMed  Google Scholar 

  • Torstveit MK, Sundgot-BorgenJ. Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: A comprehensive controlled study. Br J Sports Med 2005;39: 282–287.

    Article  PubMed  CAS  Google Scholar 

  • Torstveit MK, Sundgot-BorgenJ. Participation in leanness sports but not training volume is associated with menstrual dysfunction: A national survey of 1276 elite athletes and controls. Br J Sports Med 2005;39: 141–147.

    Article  PubMed  CAS  Google Scholar 

  • Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. IntJ Fertil 1967;12: 77–126.

    CAS  Google Scholar 

  • Van Dam EW, Roelfsema F, Veldhuis JD, Hogendoorn S, Westenberg J, Helmerhorst FM, et al. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome. Am J Physiol Endocrinol Metab 2004;286: E615–E620.

    Article  PubMed  CAS  Google Scholar 

  • Van de Lisdonk EH, Van den Bosch WJHM, Lagro-Jansen ALM, redactie. Ziekten in de huisartspraktijk. 4e dr. Maarssen: Elsevier gezondheidszorg, 2003.

    Google Scholar 

  • Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk: Klachten en aandoeningen in de bevolking en in de huisartspraktijk. Utrecht/Bilthoven: NIVEL/RIVM, 2004. http://www.nivel.nl/nationalestudie (> rapporten> kernrapport 1>5: Incidentie en prevalentie van aan de huisarts gepresenteerde klachten en aandoeningen per ICPC), geraadpleegdjanuari 2007.

  • Van der Spuy ZM, Le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev 2003;CD001125.

    Google Scholar 

  • Van der Klift M, De Laet CE, McCloskey EV, Johnell O, Kanis JA, Hofman A, et al. Risk factors for incident vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 2004;19: 1172–1180.

    Article  PubMed  Google Scholar 

  • Van Houten ME, Lammes FB. Praktische gynaecologie. Houten: Bohn Stafleu van Loghum, 2005.

    Google Scholar 

  • Van Kasteren YM. Premature ovarian failure. Therapeutical and aetiological aspects [proefschrift]. Amsterdam: Vrije Universiteit, 1999.

    Google Scholar 

  • Van Kasteren YM. Prematuur ovarieel falen. Ned Tijdschr Geneeskd 2000;144: 2142–2146.

    PubMed  Google Scholar 

  • Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001;358: 1427–1429.

    Article  PubMed  CAS  Google Scholar 

  • VerhelstJ, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2003;2: 23–32.

    Article  PubMed  Google Scholar 

  • Verri A, Nappi RE, Cecchini AP, Vallero E, Luzi S, Zara C. Eating disorders and Axis I psychiatric comorbidity in amenorrheic women. Int J Eat Disord 1998;24: 137–146.

    Article  PubMed  CAS  Google Scholar 

  • Westendorp IC, Ankum WM, Mol BW, Vonk J. Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod 1998;13: 3347–3350.

    Article  PubMed  CAS  Google Scholar 

  • Wieringa-de Waard M, Vos J, Bonsel GJ, Bindels PJ, Ankum WM. Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. Hum Reprod 2002;17: 2445–2450.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Tj. Wiersma F. S. Boukes R. M. M. Geijer A. N. Goudswaard

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Bohn Stafeu van Loghum

About this chapter

Cite this chapter

Leusink, L.G., Oltheten, T.M.J., Brugemann, M.E.L., Belgraver, A., Geertman, A.M.J., Van Balen, M.A.J. (2009). NHG-Standaard Amenorroe. In: Wiersma, T., Boukes, F.S., Geijer, R.M.M., Goudswaard, A.N. (eds) NHG-Standaarden 2009. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-6614-9_31

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-6614-9_31

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-5283-8

  • Online ISBN: 978-90-313-6614-9

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics